Black Friday Get Elite for just $149.00 Claim Now

Healthcare ETFs Shine as Investors Rotate Out of Tech

By Neena Mishra | November 19, 2026, 3:47 PM

The healthcare sector is one of the best-performing sectors this year. Over the past six months, healthcare is up about 24%, while technology is down about 6%, marking the widest divergence in performance in many years.

Many investors are moving money out of AI and technology and into defensive sectors and safer areas of the market. Healthcare has historically performed well during uncertain times, including in the run-up to the November midterm elections. Insurers and hospital operators rallied after Democrats won control of Congress.

Meanwhile, we have seen continued advances in healthcare, with new drug types and technologies emerging. In addition to the boom in GLP-1 medications, companies have announced successful clinical trials in cancer treatments and promising new cancer vaccines.

Healthcare companies have also been beating Wall Street's earnings expectations. Hospitals, insurers, and drugmakers are using AI to reduce paperwork, accelerate drug research, and operate more efficiently.

Biotech and genomics have done particularly well within the sector, as the FDA has signaled a more flexible approach to approving treatments for serious diseases. Many of these companies are leveraging AI models to design proteins, map single-cell gene activity, and conduct automated biological experiments.

Large pharmaceutical companies have plenty of cash and need new products to replace older drugs whose patents are expiring. They have been acquiring smaller, innovative biotech companies at a rapid pace to strengthen their product pipelines.

Biotech IPOs and secondary financings have also rebounded sharply, giving smaller firms fresh capital to fund clinical trials.

To learn more about these the State Street Health Care Select Sector SPDR ETF (XLV), iShares Genomics Immunology and Healthcare ETF (IDNA) and VanEck Biotech ETF (BBH), please watch the short video above.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Eli Lilly and Company (LLY): Free Stock Analysis Report
 
Moderna, Inc. (MRNA): Free Stock Analysis Report
 
State Street Health Care Select Sector SPDR ETF ETF (XLV): ETF Research Reports
 
VanEck Biotech ETF (BBH): ETF Research Reports
 
iShares Genomics Immunology and Healthcare ETF (IDNA): ETF Research Reports

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News

2 hours
3 hours
14 hours
18 hours
Nov-18
Nov-17
Nov-17
Nov-17
Nov-17
Nov-17
Nov-17
Nov-17
Nov-16
Nov-16
Nov-16